Manolo Carta, Ph.D.
Affiliations: | 2010- | Biomedical Sciences | Cagliari University |
Google:
"Manolo Carta"Mean distance: 15.36 (cluster 11)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Corsi S, Scheggi S, Pardu A, et al. (2023) Corrigendum to "Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease" [Experimental neurology 2023 May;363:114370]. Experimental Neurology. 114640 |
Serra M, Di Maio A, Bassareo V, et al. (2023) Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration. Neurobiology of Disease. 106226 |
Di Maio A, Nuzzo T, Gilio L, et al. (2023) Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients. Neurobiology of Disease. 106203 |
Corsi S, Stancampiano R, Carta M. (2021) Serotonin/dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesia: An update. Progress in Brain Research. 261: 287-302 |
Scheggi S, Rossi F, Corsi S, et al. (2020) BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia. Journal of Parkinson's Disease |
Meloni M, Puligheddu M, Sanna F, et al. (2020) Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding. Journal of the Neurological Sciences. 415: 116869 |
Waters S, Sonesson C, Svensson P, et al. (2020) Preclinical pharmacology of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine (IRL790), a novel dopamine transmission modulator for the treatment of motor and psychiatric complications in Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics |
Meloni M, Puligheddu M, Carta M, et al. (2020) Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding. European Journal of Neurology |
Corsi S, Scheggi S, Rossi F, et al. (2020) P.208 BDNF overexpression exacerbates D1R agonist-induced dyskinesia in hemiparkinsonian rats via D1R-D3R heteromers formation European Neuropsychopharmacology. 31 |
Cocco C, Corda G, Lisci C, et al. (2019) VGF peptides as novel biomarkers in Parkinson's disease. Cell and Tissue Research |